Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study - McClung, M R; Brown, J P; Diez-Perez, A (J Bone Miner Res, 2018)
Epub 2018 May 22 PMID: 29694685